3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Terminated
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Lung Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
335
Pemetrexed
276
Cisplatin
228
Paclitaxel
193
pembrolizumab
178
Erlotinib Hydrochloride
173
Docetaxel
154
Gemcitabine
126
Nivolumab
112
Bevacizumab
112
Radiotherapy
84
Etoposide
68
durvalumab
62
atezolizumab
59
Ipilimumab
51
Radiosurgery
49
osimertinib
42
130-nm albumin-bound paclitaxel
40
Afatinib
39
Gefitinib
38
Cetuximab
38
Albumin-Bound Paclitaxel
37
Taxes
32
Vinorelbine
29
Radiation
29
Topotecan
28
Drug Therapy
25
Crizotinib
23
Platinum
21
Dexamethasone
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
evolocumab
×
Thoracic
×
Clear all
NCT03337698
2026-05-12
Morpheus Lung
Hoffmann-La Roche
Phase 1/2
Terminated
314 enrolled
31 charts
NCT05144529
2026-05-05
TOP2101
Duke University
Phase 2
Terminated
19 enrolled
16 charts